Loading...

APC/Cyanine7 anti-mouse CD19 Antibody APC/Cyanine7 anti-mouse CD19 Antibody

Pricing & Availability
Clone
6D5 (See other available formats)
Regulatory Status
RUO
Other Names
B4
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
6D5_APCCyanine7_CD19_Antibody_031819_updated.png
C57BL/6 splenocytes were stained with CD3 FITC and CD19 (clone 6D5) APC/Cyaninie7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 6D5_APCCyanine7_CD19_Antibody_031819_updated.png
    C57BL/6 splenocytes were stained with CD3 FITC and CD19 (clone 6D5) APC/Cyaninie7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
115530 100 µg SEK1924
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115529 25 µg SEK941
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD19 is a 95 kD glycoprotein also known as B4. It is a member of the Ig superfamily, expressed on all pro-B to mature B cells (during development) and follicular dendritic cells. Plasma cells do not express CD19. CD19, in association with CD21 and CD81, forms a molecular complex integral to B cell activation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CD19-expressing K562 human erythroleukemia cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunofluorescence7.

Application References
  1. Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
  2. Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
  3. Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
  4. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
  5. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  6. Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
  7. Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
  8. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  9. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  10. Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
  11. Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
  12. Olive V, et al. 2013. Elife. 2:822. PubMed
  13. Miyai T, et al. 2014. PNAS. 111:11780. PubMed
Product Citations
  1. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  2. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  3. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  4. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  5. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  6. Laffleur B, et al. 2022. Sci Immunol. 7:eabn2738. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  9. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  10. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
  11. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
  12. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  13. Lütge M, et al. 2023. Nat Immunol. . PubMed
  14. Laidlaw BJ, et al. 2020. Nat Immunol. 1.626388889. PubMed
  15. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  16. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  17. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  18. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  19. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  20. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  21. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  22. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  23. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
  24. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  25. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  26. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  27. Tang J, et al. 2018. Mol Cell Biol. 38:e00103. PubMed
  28. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  29. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  30. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  31. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  32. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  33. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  34. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  35. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  36. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  37. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  38. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  39. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  40. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  41. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  42. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  43. Stone AEL, et al. 2019. Nat Commun. 10:3649. PubMed
  44. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  45. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  46. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  47. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  48. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  49. Wei SC, et al. 2020. Cancer Discov. . PubMed
  50. Ghilas S, et al. 2021. iScience. 24:103059. PubMed
  51. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  52. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  53. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  54. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  55. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  56. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  57. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  58. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  59. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  60. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  61. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  62. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  63. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  64. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  65. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  66. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  67. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  68. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  69. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  70. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  71. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  72. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  73. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  74. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  75. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  76. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  77. Elkhatib SK, et al. 2021. Biol Psychiatry Glob Open Sci. 1:190. PubMed
  78. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  79. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  80. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  81. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  82. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  83. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  84. Engblom C, et al. 2017. Science. 358:6367. PubMed
  85. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  86. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  87. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  88. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  89. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  90. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  91. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  92. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  93. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  94. Du P, et al. 2022. Front Pharmacol. 13:805508. PubMed
  95. Strawbridge R, et al. 2016. Diabetes. 65: 2888 - 2899. PubMed
  96. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  97. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  98. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  99. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  100. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  101. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  102. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  103. Chavez JS, et al. 2022. Cells. 11:. PubMed
  104. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  105. Wilson CS, et al. 2021. JCI Insight. 6:. PubMed
  106. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  107. Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed
  108. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  109. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  110. Cheng Q, et al. 2020. Eur J Immunol. 50:284. PubMed
  111. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  112. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  113. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  114. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  115. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  116. Laffleur B, et al. 2022. Sci Immunol. 7:eabn2738. PubMed
  117. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  118. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  119. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  120. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
  121. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
  122. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  123. Lütge M, et al. 2023. Nat Immunol. . PubMed
  124. Laidlaw BJ, et al. 2020. Nat Immunol. 1.626388889. PubMed
  125. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  126. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  127. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  128. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  129. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  130. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  131. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  132. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  133. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
  134. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  135. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  136. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  137. Tang J, et al. 2018. Mol Cell Biol. 38:e00103. PubMed
  138. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  139. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  140. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  141. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  142. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  143. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  144. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  145. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  146. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  147. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  148. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  149. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  150. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  151. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  152. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  153. Stone AEL, et al. 2019. Nat Commun. 10:3649. PubMed
  154. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  155. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  156. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  157. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  158. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  159. Wei SC, et al. 2020. Cancer Discov. . PubMed
  160. Ghilas S, et al. 2021. iScience. 24:103059. PubMed
  161. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  162. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  163. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  164. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  165. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  166. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  167. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  168. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  169. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  170. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  171. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  172. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  173. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  174. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  175. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  176. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  177. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  178. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  179. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  180. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  181. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  182. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  183. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  184. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  185. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  186. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  187. Elkhatib SK, et al. 2021. Biol Psychiatry Glob Open Sci. 1:190. PubMed
  188. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  189. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  190. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  191. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  192. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  193. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  194. Engblom C, et al. 2017. Science. 358:6367. PubMed
  195. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  196. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  197. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  198. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  199. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  200. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  201. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  202. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  203. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  204. Du P, et al. 2022. Front Pharmacol. 13:805508. PubMed
  205. Strawbridge R, et al. 2016. Diabetes. 65: 2888 - 2899. PubMed
  206. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  207. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  208. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  209. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  210. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  211. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  212. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  213. Chavez JS, et al. 2022. Cells. 11:. PubMed
  214. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  215. Wilson CS, et al. 2021. JCI Insight. 6:. PubMed
  216. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  217. Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed
  218. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  219. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  220. Cheng Q, et al. 2020. Eur J Immunol. 50:284. PubMed
RRID
AB_830707 (BioLegend Cat. No. 115530)
AB_830706 (BioLegend Cat. No. 115529)

Antigen Details

Structure
Ig superfamily, associates with CD21 and CD81, 95 kD
Distribution

Pro-B cells to mature B cells (during development), follicular dendritic cells

Function
Modulates B cell activation and differentiation
Ligand/Receptor
CD21, CD81, Leu-13
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.

Gene ID
12478 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD19 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD19 6D5 FC
Biotin anti-mouse CD19 6D5 FC
FITC anti-mouse CD19 6D5 FC
PE anti-mouse CD19 6D5 FC
PE/Cyanine5 anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
PE/Cyanine7 anti-mouse CD19 6D5 FC
PE/Dazzle™ 594 anti-mouse CD19 6D5 FC
Brilliant Violet 711™ anti-mouse CD19 6D5 FC
APC/Fire™ 750 anti-mouse CD19 6D5 FC
TotalSeq™-A0093 anti-mouse CD19 6D5 PG
Brilliant Violet 750™ anti-mouse CD19 6D5 FC
TotalSeq™-B0093 anti-mouse CD19 6D5 PG
Spark Blue™ 550 anti-mouse CD19 6D5 FC
Spark NIR™ 685 anti-mouse CD19 6D5 FC
TotalSeq™-C0093 anti-mouse CD19 6D5 PG
Ultra-LEAF™ Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
Alexa Fluor® 488 anti-mouse CD19 6D5 FC
Alexa Fluor® 647 anti-mouse CD19 6D5 FC,IHC-F
Pacific Blue™ anti-mouse CD19 6D5 FC
Alexa Fluor® 700 anti-mouse CD19 6D5 FC
APC/Cyanine7 anti-mouse CD19 6D5 FC
PerCP anti-mouse CD19 6D5 FC
PerCP/Cyanine5.5 anti-mouse CD19 6D5 FC
Alexa Fluor® 594 anti-mouse CD19 6D5 IHC-F,FC
Brilliant Violet 421™ anti-mouse CD19 6D5 FC,IHC-F
Brilliant Violet 570™ anti-mouse CD19 6D5 FC
Brilliant Violet 605™ anti-mouse CD19 6D5 FC
Brilliant Violet 650™ anti-mouse CD19 6D5 FC
Brilliant Violet 785™ anti-mouse CD19 6D5 FC
Brilliant Violet 510™ anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 (Maxpar® Ready) 6D5 FC,CyTOF®
PE/Fire™ 640 anti-mouse CD19 Antibody 6D5 FC
Spark YG™ 581 anti-mouse CD19 6D5 FC
APC/Fire™ 810 anti-mouse CD19 6D5 FC
Spark YG™ 570 anti-mouse CD19 6D5 IHC-F
Spark Blue™ 574 anti-mouse CD19 Antibody 6D5 FC
Spark Blue™ 515 anti-mouse CD19 6D5 FC
Spark UV™ 387 anti-mouse CD19 6D5 FC
Spark Red™ 718 anti-mouse CD19 (Flexi-Fluor™) 6D5 FC
Spark PLUS UV395™ anti-mouse CD19 6D5 FC
Spark Violet™ 538 anti-mouse CD19 6D5 FC
PerCP/Fire™ 780 anti-mouse CD19 Antibody 6D5 FC
PerCP/Fire™ 806 anti-mouse CD19 Antibody 6D5 FC
Spark YG™ 593 anti-mouse CD19 (Flexi-Fluor™) Antibody 6D5 FC
Go To Top Version: 3    Revision Date: 03-18-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
6D5 (See other available formats)
Regulatory Status
RUO
Other Names
B4
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
6D5_APCCyanine7_CD19_Antibody_031819_updated.png
C57BL/6 splenocytes were stained with CD3 FITC and CD19 (clone 6D5) APC/Cyaninie7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 6D5_APCCyanine7_CD19_Antibody_031819_updated.png
    C57BL/6 splenocytes were stained with CD3 FITC and CD19 (clone 6D5) APC/Cyaninie7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
115530 100 µg SEK1924
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115529 25 µg SEK941
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD19 is a 95 kD glycoprotein also known as B4. It is a member of the Ig superfamily, expressed on all pro-B to mature B cells (during development) and follicular dendritic cells. Plasma cells do not express CD19. CD19, in association with CD21 and CD81, forms a molecular complex integral to B cell activation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CD19-expressing K562 human erythroleukemia cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunofluorescence7.

Application References
  1. Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
  2. Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
  3. Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
  4. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
  5. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  6. Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
  7. Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
  8. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  9. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  10. Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
  11. Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
  12. Olive V, et al. 2013. Elife. 2:822. PubMed
  13. Miyai T, et al. 2014. PNAS. 111:11780. PubMed
Product Citations
  1. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  2. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  3. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  4. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  5. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  6. Laffleur B, et al. 2022. Sci Immunol. 7:eabn2738. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  9. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  10. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
  11. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
  12. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  13. Lütge M, et al. 2023. Nat Immunol. . PubMed
  14. Laidlaw BJ, et al. 2020. Nat Immunol. 1.626388889. PubMed
  15. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  16. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  17. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  18. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  19. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  20. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  21. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  22. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  23. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
  24. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  25. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  26. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  27. Tang J, et al. 2018. Mol Cell Biol. 38:e00103. PubMed
  28. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  29. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  30. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  31. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  32. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  33. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  34. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  35. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  36. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  37. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  38. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  39. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  40. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  41. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  42. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  43. Stone AEL, et al. 2019. Nat Commun. 10:3649. PubMed
  44. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  45. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  46. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  47. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  48. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  49. Wei SC, et al. 2020. Cancer Discov. . PubMed
  50. Ghilas S, et al. 2021. iScience. 24:103059. PubMed
  51. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  52. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  53. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  54. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  55. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  56. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  57. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  58. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  59. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  60. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  61. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  62. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  63. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  64. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  65. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  66. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  67. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  68. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  69. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  70. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  71. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  72. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  73. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  74. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  75. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  76. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  77. Elkhatib SK, et al. 2021. Biol Psychiatry Glob Open Sci. 1:190. PubMed
  78. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  79. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  80. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  81. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  82. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  83. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  84. Engblom C, et al. 2017. Science. 358:6367. PubMed
  85. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  86. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  87. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  88. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  89. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  90. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  91. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  92. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  93. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  94. Du P, et al. 2022. Front Pharmacol. 13:805508. PubMed
  95. Strawbridge R, et al. 2016. Diabetes. 65: 2888 - 2899. PubMed
  96. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  97. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  98. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  99. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  100. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  101. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  102. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  103. Chavez JS, et al. 2022. Cells. 11:. PubMed
  104. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  105. Wilson CS, et al. 2021. JCI Insight. 6:. PubMed
  106. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  107. Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed
  108. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  109. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  110. Cheng Q, et al. 2020. Eur J Immunol. 50:284. PubMed
  111. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  112. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  113. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  114. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  115. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  116. Laffleur B, et al. 2022. Sci Immunol. 7:eabn2738. PubMed
  117. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  118. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  119. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  120. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
  121. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
  122. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  123. Lütge M, et al. 2023. Nat Immunol. . PubMed
  124. Laidlaw BJ, et al. 2020. Nat Immunol. 1.626388889. PubMed
  125. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  126. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  127. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  128. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  129. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  130. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  131. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  132. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  133. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
  134. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  135. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  136. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  137. Tang J, et al. 2018. Mol Cell Biol. 38:e00103. PubMed
  138. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  139. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  140. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  141. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  142. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  143. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  144. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  145. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  146. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  147. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  148. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  149. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  150. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  151. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  152. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  153. Stone AEL, et al. 2019. Nat Commun. 10:3649. PubMed
  154. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  155. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  156. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  157. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  158. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  159. Wei SC, et al. 2020. Cancer Discov. . PubMed
  160. Ghilas S, et al. 2021. iScience. 24:103059. PubMed
  161. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  162. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  163. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  164. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  165. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  166. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  167. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  168. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  169. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  170. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  171. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  172. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  173. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  174. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  175. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  176. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  177. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  178. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  179. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  180. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  181. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  182. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  183. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  184. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  185. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  186. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  187. Elkhatib SK, et al. 2021. Biol Psychiatry Glob Open Sci. 1:190. PubMed
  188. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  189. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  190. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  191. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  192. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  193. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  194. Engblom C, et al. 2017. Science. 358:6367. PubMed
  195. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  196. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  197. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  198. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  199. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  200. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  201. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  202. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  203. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  204. Du P, et al. 2022. Front Pharmacol. 13:805508. PubMed
  205. Strawbridge R, et al. 2016. Diabetes. 65: 2888 - 2899. PubMed
  206. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  207. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  208. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  209. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  210. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  211. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  212. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  213. Chavez JS, et al. 2022. Cells. 11:. PubMed
  214. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  215. Wilson CS, et al. 2021. JCI Insight. 6:. PubMed
  216. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  217. Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed
  218. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  219. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  220. Cheng Q, et al. 2020. Eur J Immunol. 50:284. PubMed
RRID
AB_830707 (BioLegend Cat. No. 115530)
AB_830706 (BioLegend Cat. No. 115529)

Antigen Details

Structure
Ig superfamily, associates with CD21 and CD81, 95 kD
Distribution

Pro-B cells to mature B cells (during development), follicular dendritic cells

Function
Modulates B cell activation and differentiation
Ligand/Receptor
CD21, CD81, Leu-13
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.

Gene ID
12478 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

Other Formats

View All CD19 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD19 6D5 FC
Biotin anti-mouse CD19 6D5 FC
FITC anti-mouse CD19 6D5 FC
PE anti-mouse CD19 6D5 FC
PE/Cyanine5 anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
PE/Cyanine7 anti-mouse CD19 6D5 FC
PE/Dazzle™ 594 anti-mouse CD19 6D5 FC
Brilliant Violet 711™ anti-mouse CD19 6D5 FC
APC/Fire™ 750 anti-mouse CD19 6D5 FC
TotalSeq™-A0093 anti-mouse CD19 6D5 PG
Brilliant Violet 750™ anti-mouse CD19 6D5 FC
TotalSeq™-B0093 anti-mouse CD19 6D5 PG
Spark Blue™ 550 anti-mouse CD19 6D5 FC
Spark NIR™ 685 anti-mouse CD19 6D5 FC
TotalSeq™-C0093 anti-mouse CD19 6D5 PG
Ultra-LEAF™ Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
Alexa Fluor® 488 anti-mouse CD19 6D5 FC
Alexa Fluor® 647 anti-mouse CD19 6D5 FC,IHC-F
Pacific Blue™ anti-mouse CD19 6D5 FC
Alexa Fluor® 700 anti-mouse CD19 6D5 FC
APC/Cyanine7 anti-mouse CD19 6D5 FC
PerCP anti-mouse CD19 6D5 FC
PerCP/Cyanine5.5 anti-mouse CD19 6D5 FC
Alexa Fluor® 594 anti-mouse CD19 6D5 IHC-F,FC
Brilliant Violet 421™ anti-mouse CD19 6D5 FC,IHC-F
Brilliant Violet 570™ anti-mouse CD19 6D5 FC
Brilliant Violet 605™ anti-mouse CD19 6D5 FC
Brilliant Violet 650™ anti-mouse CD19 6D5 FC
Brilliant Violet 785™ anti-mouse CD19 6D5 FC
Brilliant Violet 510™ anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 (Maxpar® Ready) 6D5 FC,CyTOF®
PE/Fire™ 640 anti-mouse CD19 Antibody 6D5 FC
Spark YG™ 581 anti-mouse CD19 6D5 FC
APC/Fire™ 810 anti-mouse CD19 6D5 FC
Spark YG™ 570 anti-mouse CD19 6D5 IHC-F
Spark Blue™ 574 anti-mouse CD19 Antibody 6D5 FC
Spark Blue™ 515 anti-mouse CD19 6D5 FC
Spark UV™ 387 anti-mouse CD19 6D5 FC
Spark Red™ 718 anti-mouse CD19 (Flexi-Fluor™) 6D5 FC
Spark PLUS UV395™ anti-mouse CD19 6D5 FC
Spark Violet™ 538 anti-mouse CD19 6D5 FC
PerCP/Fire™ 780 anti-mouse CD19 Antibody 6D5 FC
PerCP/Fire™ 806 anti-mouse CD19 Antibody 6D5 FC
Spark YG™ 593 anti-mouse CD19 (Flexi-Fluor™) Antibody 6D5 FC
Go To Top Version: 3    Revision Date: 03-18-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account